Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.
NCT06706466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 410
Last updated 2024-11-26
Summary
The SIIR during neoadjuvant therapy can serve as a specific biomarker for predicting the efficacy of immunotherapy in patients with advanced gastric cancer.
Conditions
- Immunotherapy Gastrict Cancer
- Inflammation Biomarkers
- Gastric Cancers
Interventions
- OTHER
-
observational study
Non-interventional
Sponsors & Collaborators
-
Chang-Ming Huang, Prof.
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2021-12-31
- Completion
- 2024-05-01
Countries
- China
Study Locations
More Related Trials
-
Prediction of the Chronicization of Radiation-induced Acute Intestinal Injury
NCT05749484 ·Status: NOT_YET_RECRUITING
-
Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy
NCT05465512 ·Status: COMPLETED
-
The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)
NCT07160647 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy
NCT06946745 ·Status: RECRUITING
-
An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy
NCT07263620 ·Status: RECRUITING
-
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
NCT06613165 ·Status: RECRUITING
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING
-
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
NCT05515796 ·Status: COMPLETED ·Phase: PHASE2
-
Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer
NCT06432075 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer
NCT07134218 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients
NCT06098560 ·Status: RECRUITING
-
Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer
NCT06364371 ·Status: RECRUITING
-
Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration
NCT06396143 ·Status: RECRUITING
-
An Observational Study of Perioperative Immunotherapy in MSI-H Gastrointestinal Tumors
NCT04640103 ·Status: UNKNOWN
-
Evaluation of Inflammatory Markers in LARC Patients
NCT05893667 ·Status: COMPLETED
-
Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy
NCT02554448 ·Status: UNKNOWN ·Phase: NA
-
Impact of Robotic Surgery on Systemic Immune-inflammation Index
NCT06811753 ·Status: COMPLETED
-
A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer
NCT06746298 ·Status: NOT_YET_RECRUITING
-
Study on the Applicability of CCR Criteria in Rectal Cancer
NCT06794099 ·Status: COMPLETED
-
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
NCT05969938 ·Status: UNKNOWN
-
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer
NCT04227886 ·Status: UNKNOWN
-
Tumor Immunotherapy and Microbiome Analysis
NCT04579978 ·Status: UNKNOWN
-
Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis
NCT03149978 ·Status: UNKNOWN
-
The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer
NCT04598984 ·Status: UNKNOWN
-
Integrating Multi-Omics Data for Enhanced Prognosis Prediction in Gastric Cancer Post-Neoadjuvant Therapy
NCT07190040 ·Status: COMPLETED